Linda Halldner

3.9k total citations · 1 hit paper
34 papers, 2.7k citations indexed

About

Linda Halldner is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Physiology. According to data from OpenAlex, Linda Halldner has authored 34 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 13 papers in Cognitive Neuroscience and 11 papers in Physiology. Recurrent topics in Linda Halldner's work include Attention Deficit Hyperactivity Disorder (14 papers), Adenosine and Purinergic Signaling (11 papers) and Autism Spectrum Disorder Research (9 papers). Linda Halldner is often cited by papers focused on Attention Deficit Hyperactivity Disorder (14 papers), Adenosine and Purinergic Signaling (11 papers) and Autism Spectrum Disorder Research (9 papers). Linda Halldner collaborates with scholars based in Sweden, United States and United Kingdom. Linda Halldner's co-authors include Bertil B. Fredholm, Niklas Långström, Paul Lichtenstein, Henrik Larsson, Giulia Arslan, Gunnar Schulte, Björn Kull, Wyeth W. Wasserman, Johan Zetterqvist and Björn Johansson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Linda Halldner

32 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medication for Attention Deficit–Hyperactivity Disorder and Criminality

2012 391 citations Paul Lichtenstein, Linda Halldner et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Linda Halldner

Since Specialization

Citations

This map shows the geographic impact of Linda Halldner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Halldner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Halldner more than expected).

Fields of papers citing papers by Linda Halldner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Halldner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Halldner. The network helps show where Linda Halldner may publish in the future.

Co-authorship network of co-authors of Linda Halldner

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Halldner. A scholar is included among the top collaborators of Linda Halldner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Halldner. Linda Halldner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children 2025 ·JAMA Pediatrics ·Viktor Wintzell, Philip Brenner, Linda Halldner, Samuel Rhedin, Tong Gong, Catarina Almqvist	3
2	Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks 2025 ·Acta Paediatrica ·(unknown), Jenny M. Kindblom, Linda Halldner, David Gyllenberg, Estelle Naumburg	0
3	Symptom similarities and differences in social interaction between autistic children and adolescents with and without ADHD 2023 ·Current Psychology ·(unknown), Linda Halldner, (unknown), (unknown), Sven Bölte, Nora Choque Olsson	2
4	Childhood-onset versus adolescent-onset anxiety and depression: Epidemiological and neurodevelopmental aspects 2022 ·Psychiatry Research ·(unknown), Linda Halldner, Henrik Larsson, Christopher Gillberg, Ralf Kuja‐Halkola, Paul Lichtenstein, Sebastian Lundström	9
5	Internalizing symptoms in adolescence are modestly affected by symptoms of anxiety, depression, and neurodevelopmental disorders in childhood 2022 ·BMC Psychiatry ·(unknown), Henrik Larsson, Linda Halldner, Christopher Gillberg, Ralf Kuja‐Halkola, Sebastian Lundström	6
6	The relationship between intelligence and global adaptive functioning in young people with or without neurodevelopmental disorders 2021 ·Psychiatry Research ·Jakob Åsberg Johnels, (unknown), Eva Billstedt, Christopher Gillberg, Linda Halldner, Maria Råstam, Peik Gustafsson, (unknown), Paul Lichtenstein, Clara Hellner, Henrik Anckarsäter, Sebastian Lundström	10
7	Medications for attention-deficit/hyperactivity disorder in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register 2020 ·Journal of Neurodevelopmental Disorders ·Viktoria Johansson, Sven Sandin, Zheng Chang, Mark J. Taylor, Paul Lichtenstein, Brian M. D’Onofrio, Henrik Larsson, Clara Hellner, Linda Halldner	5
8	Trends in childhood and adolescent internalizing symptoms: results from Swedish population based twin cohorts 2019 ·BMC Psychology ·Natalie Durbeej, Karolina Sörman, (unknown), Sebastian Lundström, Paul Lichtenstein, Clara Hellner, Linda Halldner	51
9	Childhood neurodevelopmental problems and adolescent bully victimization: population-based, prospective twin study in Sweden 2015 ·European Child & Adolescent Psychiatry ·(unknown), Erik Pettersson, Paul Lichtenstein, Henrik Anckarsäter, Sebastian Lundström, Clara Hellner Gumpert, Henrik Larsson, Linnéa Kollberg, Niklas Långström, Linda Halldner	13
10	A study of the possible association between adenosine A_2A receptor gene polymorphisms and attention‐deficit hyperactivity disorder traits 2013 ·Genes Brain & Behavior ·Yasmina Molero, Clara Hellner Gumpert, Eva Serlachius, Paul Lichtenstein, Hasse Walum, Daniel Johansson, Henrik Anckarsäter, Lars Westberg, Elias Eriksson, Linda Halldner	31
11	Stimulant and non‐stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009 2012 ·Acta Psychiatrica Scandinavica ·Johan Zetterqvist, Philip Asherson, Linda Halldner, Niklas Långström, Henrik Larsson	129
12	Medication for Attention Deficit–Hyperactivity Disorder and Criminality breakdown → 2012 ·New England Journal of Medicine ·Paul Lichtenstein, Linda Halldner, Johan Zetterqvist, Arvid Sjölander, Eva Serlachius, Seena Fazel, Niklas Långström, Henrik Larsson	391
13	The Child and Adolescent Twin Study in Sweden (CATSS) 2011 ·Twin Research and Human Genetics ·Henrik Anckarsäter, Sebastian Lundström, Linnéa Kollberg, Nóra Kerekes, Camilla Palm, Eva Carlström, Niklas Långström, Patrik K. E. Magnusson, Linda Halldner, Sven Bölte, Christopher Gillberg, Clara Hellner Gumpert, Maria Råstam, Paul Lichtenstein	227
14	Mice lacking the adenosine A₁ receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly 2005 ·Synapse ·Lydia Giménez‐Llort, Susan A. Masino, Lihong Diao, Alberto Fernández‐Teruel, Adolf Tobeña, Linda Halldner, Bertil B. Fredholm	52
15	Increased nociceptive response in mice lacking the adenosine A1 receptor 2004 ·Pain ·Weiping Wu, Jing‐Xia Hao, Linda Halldner, Cecilia Lövdahl, Gary E. DeLander, Zsuzsanna Wiesenfeld‐Hallin, Bertil B. Fredholm, Xiao‐Jun Xu	105
16	Binding of the prototypical adenosine A_2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A₁ and A_2A receptor knockout mice 2004 ·British Journal of Pharmacology ·Luı́sa V. Lopes, Linda Halldner, Nelson Rebola, Björn Johansson, Catherine Ledent, (unknown), Bertil B. Fredholm, Rodrigo A. Cunha	88
17	Sleep and its homeostatic regulation in mice lacking the adenosine A₁receptor 2003 ·Journal of Sleep Research ·Dag Stenberg, Erik Litonius, Linda Halldner, Björn Johansson, Bertil B. Fredholm, Tarja Porkka‐Heiskanen	117
18	Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors 2002 ·Neuroscience ·(unknown), Jianjun Hao, Linda Halldner, Xiaobo Xu, Marlene A. Jacobson, Zsuzsanna Wiesenfeld‐Hallin, Bertil B. Fredholm	41
19	Lack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist 2000 ·European Journal of Pharmacology ·Linda Halldner, Gianluca Lozza, Karin Lindström, Bertil B. Fredholm	46
20	Structure and function of adenosine receptors and their genes 2000 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Bertil B. Fredholm, Giulia Arslan, Linda Halldner, Björn Kull, Gunnar Schulte, Wyeth W. Wasserman	484

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact